ABSTRACT

Coronavirus Vaccine Manufacturing Failures of Emergent Biosolutions   [open pdf - 2MB]

From the Executive Summary: "This staff report was prepared for Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, following an investigation into the Trump Administration's award of a multimillion-dollar contract to Emergent BioSolutions, Inc. (Emergent) to manufacture coronavirus vaccines despite a history of serious deficiencies. The report includes the following key findings: 'Nearly 400 million doses of coronavirus vaccines have been destroyed as a result of Emergent's failure to meet or maintain quality standards.' [...] 'Emergent executives promoted the company's manufacturing capabilities despite being warned of severe deficiencies.' [...] 'FDA, Johnson & Johnson, and AstraZeneca identified multiple deficiencies at Bayview, which Emergent failed to remediate despite urgent warnings.' [...] 'Inexperienced staff and high staff turnover contributed to vaccine contamination.' [...] 'HHS terminated its contract with Emergent because the company failed to follow federal manufacturing standards.'"

Author:
Publisher:
Date:
2022-05
Series:
Copyright:
Public Domain
Retrieved From:
Select Subcommittee on the Coronavirus Crisis: https://coronavirus.house.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations